Previous 10 |
The NASDAQ Biotechnology Index (INDEXNASDAQ: NBI ) was on the decline last week, dropping from 3,269.13 points on Monday (June 10) to 3,238.69 points as of 2:08 p.m. EDT on Friday (June 14). Last week, Provention Bio (NASDAQ: PRVB ) announced a public offering of its common stock on Monday...
Nes Ziona, Israel, June 06, 2019 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today provided a clinical update on the positive safety profile of its off-the-shelf cell therapy, Allocetra TM , in the first three severe sepsis p...
Nes-Ziona, Israel, May 30, 2019 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq:ENLV), a clinical-stage immunotherapy company, today announced that company management will make a corporate presentation at the Jefferies Global Healthcare 2019 conference being held in New York C...
Gainers: Roan Resources (NYSE: ROAN ) +41% . Alterity Therapeutics (NASDAQ: ATHE ) +32% . Changyou.com (NASDAQ: CYOU ) +22% . Sohu.com (NASDAQ: SOHU ) +19% . Enlivex Therapeutics (NASDAQ: ENLV ) +19% . Gardner Denver Holdings (NYSE: GDI ) +16% . Provention Bio (NASDAQ: PRVB ) ...
Nes Ziona, Israel, April 18, 2019 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today announced that the Israel Innovation Authority (IIA) selected the Company’s clinical program for prevention of cytokine storms and org...
Gainers: Reebonz Holding (NASDAQ: RBZ ) +111% . Castor Maritime (NASDAQ: CTRM ) +43% . Anadarko Petroleum (NYSE: APC ) +33% . Immuron (NASDAQ: IMRN ) +27% . Enlivex Therapeutics (NASDAQ: ENLV ) +17% . Kitov Pharma (NASDAQ: KTOV ) +17% . Renren (NYSE: RENN ) +15% . Summit Wirel...
Nes Ziona, Israel, April 08, 2019 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today announced the final closing of a private placement financing of ordinary shares priced at $12.25 per share, raising a total of approximately $8.4 mil...
News, Short Squeeze, Breakout and More Instantly...
Enlivex Therapeutics Ltd. Company Name:
ENLV Stock Symbol:
NASDAQ Market:
Enlivex Therapeutics Ltd. Website:
• First study of Allocetra TM in psoriatic arthritis, a chronic inflammatory condition that causes joint pain, swelling and stiffness, affects as many as 30% of people with psoriasis 1 , and has limited treatment options Nes-Ziona, Israel, July 23, 2024 (GLOB...
ORLANDO, FL / ACCESSWIRE / July 19, 2024 / RedChip Companies will air interviews with Enlivex Therapeutics Ltd. (Nasdaq:ENLV) and Biotricity, Inc. (Nasdaq:BTCY) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, July 20, at 7 p.m. Eastern T...
First patient dosed with Allocetra TM in thumb osteoarthritis, a degenerative, debilitating and progressive disease that affects millions of people Thumb osteoarthritis currently has no FDA-approved therapy and no effective long-term treatments Ness-Ziona, Israel, June 24, 2024 (GLO...